{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:18:29Z","timestamp":1792671509655,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.vaccine.2011.04.053","type":"journal-article","created":{"date-parts":[[2011,5,8]],"date-time":"2011-05-08T13:30:03Z","timestamp":1304861403000},"page":"4881-4890","source":"Crossref","is-referenced-by-count":82,"title":["Comparative effects of carrier proteins on vaccine-induced immune response"],"prefix":"10.1016","volume":"29","author":[{"given":"Markus","family":"Knuf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Kowalzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothee","family":"Kieninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.04.053_bib0005","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1128\/CMR.19.1.142-164.2006","article-title":"Prospects for vaccine prevention of meningococcal infection","volume":"19","author":"Harrison","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"September (41)","key":"10.1016\/j.vaccine.2011.04.053_bib0010","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1016\/j.vaccine.2009.07.036","article-title":"Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages","volume":"27","author":"Broker","year":"2009","journal-title":"Vaccine"},{"issue":"March (11)","key":"10.1016\/j.vaccine.2011.04.053_bib0015","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.vaccine.2009.01.005","article-title":"The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants","volume":"27","author":"Pollabauer","year":"2009","journal-title":"Vaccine"},{"issue":"October (2)","key":"10.1016\/j.vaccine.2011.04.053_bib0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2567.2004.01971.x","article-title":"Haemophilus influenzae type b conjugate vaccines","volume":"113","author":"Kelly","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2011.04.053_bib0025","unstructured":"ACTHib [package insert]. Swiftwater, PA: Sanofi Pasteur; 2005."},{"key":"10.1016\/j.vaccine.2011.04.053_bib0030","unstructured":"Menactra [package insert]. Swiftwater, PA: Sanofi Pasteur; 2009."},{"key":"10.1016\/j.vaccine.2011.04.053_bib0035","unstructured":"PedvaxHIB [package insert]. West Point, PA: Merck and Co., Inc.; 2001."},{"issue":"March (5)","key":"10.1016\/j.vaccine.2011.04.053_bib0040","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1086\/527396","article-title":"Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines","volume":"46","author":"Forsgren","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2011.04.053_bib0045","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1128\/AEM.46.3.560-564.1983","article-title":"Isolation and characterization of Corynebacterium diphtheriae nontandem double lysogens hyperproducing CRM197","volume":"46","author":"Rappuoli","year":"1983","journal-title":"Appl Environ Microbiol"},{"issue":"February (24)","key":"10.1016\/j.vaccine.2011.04.053_bib0050","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1126\/science.175.4024.901","article-title":"Reconstitution of diphtheria toxin from two nontoxic cross-reacting mutant proteins","volume":"175","author":"Uchida","year":"1972","journal-title":"Science"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.04.053_bib0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/IAI.3.1.133-140.1971","article-title":"Amino acid analysis and molecular weight determination of tetanus toxin","volume":"3","author":"Holmes","year":"1971","journal-title":"Infect Immun"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2011.04.053_bib0060","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1073\/pnas.89.10.4633","article-title":"A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes","volume":"89","author":"Liu","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"February (2 Pt 1)","key":"10.1016\/j.vaccine.2011.04.053_bib0065","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0022-3476(05)80424-X","article-title":"Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines","volume":"120","author":"Decker","year":"1992","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2011.04.053_bib0070","unstructured":"Hiberix [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2009."},{"key":"10.1016\/j.vaccine.2011.04.053_bib0075","unstructured":"Menitorix [summary of product characteristics]. Uxbridge, United Kingdom: GlaxoSmithKline; 2009."},{"key":"10.1016\/j.vaccine.2011.04.053_bib0080","unstructured":"NeisVac-C [product monograph]. Mississauga, Canada: GlaxoSmithKline Inc.; 2009."},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.04.053_bib0085","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1086\/599117","article-title":"Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents","volume":"49","author":"Jackson","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"January (3)","key":"10.1016\/j.vaccine.2011.04.053_bib0090","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.vaccine.2009.10.064","article-title":"A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young children","volume":"28","author":"Knuf","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.04.053_bib0095","unstructured":"Meningitec [product monograph]. Quebec, Canada: Wyeth; 2007."},{"key":"10.1016\/j.vaccine.2011.04.053_bib0100","unstructured":"Menjugate [summary of product characteristics]. Sienna, Italy: Novartis Vaccines and Diagnostics; 2009."},{"key":"10.1016\/j.vaccine.2011.04.053_bib0105","unstructured":"Prevnar [package insert]. Philadelphia, PA; Wyeth Pharmaceuticals; 2009."},{"key":"10.1016\/j.vaccine.2011.04.053_bib0110","unstructured":"Vaxem Hib [summary of product characteristics]. Sienna, Italy: Novartis Vaccines and Diagnostics; 2007."},{"issue":"June (21)","key":"10.1016\/j.vaccine.2011.04.053_bib0115","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1001\/jama.283.21.2795","article-title":"Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: a randomized controlled trial","volume":"283","author":"MacLennan","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.04.053_bib0120","unstructured":"Prevnar 13 [package insert]. Philadelphia, PA; Wyeth Pharmaceuticals; 2010."},{"issue":"June (7659)","key":"10.1016\/j.vaccine.2011.04.053_bib0125","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/bmj.39563.545255.AE","article-title":"Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study","volume":"336","author":"Snape","year":"2008","journal-title":"BMJ"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2011.04.053_bib0130","first-page":"173","article-title":"Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial","volume":"299","author":"Snape","year":"2008","journal-title":"JAMA"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.04.053_bib0135","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/CVI.00420-08","article-title":"Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom","volume":"16","author":"Southern","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.04.053_bib0140","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/317646","article-title":"Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers","volume":"183","author":"Richmond","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.04.053_bib0145","unstructured":"Menveo [package insert]. Cambridge, MA: Novartis Vaccines and Diagnostics; 2010."},{"issue":"June (Suppl. 2)","key":"10.1016\/j.vaccine.2011.04.053_bib0150","doi-asserted-by":"crossref","first-page":"B30","DOI":"10.1016\/j.vaccine.2009.05.003","article-title":"Quadrivalent meningococcal conjugate vaccines","volume":"27","author":"Pace","year":"2009","journal-title":"Vaccine"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.04.053_bib0155","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/INF.0b013e31818e037d","article-title":"Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants","volume":"28","author":"Perrett","year":"2009","journal-title":"Pediatr Infect Dis Z J"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.04.053_bib0160","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/01.inf.0000126297.28952.f8","article-title":"Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine in infants","volume":"23","author":"Rennels","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"March (Suppl. 2)","key":"10.1016\/j.vaccine.2011.04.053_bib0165","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1086\/648966","article-title":"Review of meningococcal group B vaccines","volume":"50","author":"Granoff","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2011.04.053_bib0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1586\/14760584.7.1.97","article-title":"Combination vaccines containing DTPa-Hib: impact of IPV and coadministration of CRM197 conjugates","volume":"7","author":"Dagan","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2011.04.053_bib0175","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-3476(05)81186-2","article-title":"Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants","volume":"121","author":"Granoff","year":"1992","journal-title":"J Pediatr"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.04.053_bib0180","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3346\/jkms.2010.25.1.90","article-title":"Immunogenicity of Haemophilus influenzae type b conjugate vaccines in Korean infants: a meta-analysis","volume":"25","author":"Lee","year":"2010","journal-title":"J Korean Med Sci"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.04.053_bib0185","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"March (9512)","key":"10.1016\/j.vaccine.2011.04.053_bib0190","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":"Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.04.053_bib0195","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/00006454-199711000-00010","article-title":"Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens","volume":"16","author":"Dagan","year":"1997","journal-title":"Pediatr Infect Dis J"},{"issue":"June (27)","key":"10.1016\/j.vaccine.2011.04.053_bib0200","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1016\/j.vaccine.2010.04.072","article-title":"Overview of the development and current use of CRM(197) conjugate vaccines for pediatric use","volume":"28","author":"Shinefield","year":"2010","journal-title":"Vaccine"},{"issue":"August (34)","key":"10.1016\/j.vaccine.2011.04.053_bib0205","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","article-title":"Glycoconjugate vaccines and immune interference: a review","volume":"28","author":"Dagan","year":"2010","journal-title":"Vaccine"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.04.053_bib0210","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1128\/IAI.66.5.2093-2098.1998","article-title":"Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants","volume":"66","author":"Dagan","year":"1998","journal-title":"Infect Immun"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.04.053_bib0215","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1128\/IAI.72.9.5383-5391.2004","article-title":"Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components","volume":"72","author":"Dagan","year":"2004","journal-title":"Infect Immun"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.04.053_bib0220","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/adc.2005.076109","article-title":"Evaluation of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age","volume":"92","author":"Kitchin","year":"2007","journal-title":"Arch Dis Child"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2011.04.053_bib0225","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vaccine.2005.07.060","article-title":"Immunogenicity of one, two or three doses of a meningococcal C conjugate vaccine conjugated to tetanus toxoid, given as a three-dose primary vaccination course in UK infants at 2, 3 and 4 months of age with acellular pertussis-containing DTP\/Hib vaccine","volume":"24","author":"Southern","year":"2006","journal-title":"Vaccine"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.04.053_bib0230","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/CVI.00377-06","article-title":"Immunogenicity, reactogenicity, and immune memory after primary vaccination with a novel Haemophilus influenzae\u2013Neisseria meningitidis serogroup C conjugate vaccine","volume":"14","author":"Schmitt","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"August (35)","key":"10.1016\/j.vaccine.2011.04.053_bib0235","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1016\/j.vaccine.2008.05.087","article-title":"A clinical trial examining the effect of increased total CRM(197) carrier protein dose on the antibody response to Haemophilus influenzae type b CRM(197) conjugate vaccine","volume":"26","author":"Usonis","year":"2008","journal-title":"Vaccine"},{"issue":"April (14)","key":"10.1016\/j.vaccine.2011.04.053_bib0240","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1001\/jama.293.14.1751","article-title":"Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial","volume":"293","author":"Buttery","year":"2005","journal-title":"JAMA"},{"issue":"April (4 Suppl.)","key":"10.1016\/j.vaccine.2011.04.053_bib0245","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/INF.0b013e318199f61b","article-title":"Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV)","volume":"28","author":"Knuf","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"November (20)","key":"10.1016\/j.vaccine.2011.04.053_bib0250","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJM199011153232006","article-title":"Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. The Alaska H. influenzae Vaccine Study Group","volume":"323","author":"Ward","year":"1990","journal-title":"N Engl J Med"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.04.053_bib0255","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00006454-199102000-00004","article-title":"Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group","volume":"10","author":"Black","year":"1991","journal-title":"Pediatr Infect Dis J"},{"issue":"September (13)","key":"10.1016\/j.vaccine.2011.04.053_bib0260","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJM197709292971302","article-title":"Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age","volume":"297","author":"Peltola","year":"1977","journal-title":"N Engl J Med"},{"issue":"10 Suppl. 1","key":"10.1016\/j.vaccine.2011.04.053_bib0265","first-page":"S7","article-title":"ASM LabCap's contributions to disease surveillance and the International Health Regulations","author":"Specter","year":"2005","journal-title":"BMC Public Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11005986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11005986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:17:37Z","timestamp":1592525857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11005986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":53,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0264410X11005986"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.04.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}